top of page
Search Results

108 items found for "Young Chan Chae"

  • 📰 GPCR Weekly News, September 25 to October 1, 2023

    Unfortunately, registration has closed, but you can still join the waitlist by emailing gpcrretreat@uottawa.ca You can submit your logo design by November 1st, and registration is unnecessary to participate. You can find all the necessary information on the Logo Contest page. Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting

  • 📰 GPCR Weekly News, September 18 to 24, 2023

    If you couldn't make it, no sweat – our premium members can always go back and watch the recorded talks Registration is now closed, but you can join the waitlist by emailing gpcrretreat@uottawa.ca. Novo Nordisk's North Carolina semaglutide plant Excellerate Bioscience Announces Site Relocation AI can Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting

  • 📰 GPCR Weekly News, September 11 to 17, 2023

    Registrations are closed but you can send an email to gpcrretreat@uottawa.ca to be added to the waitlist Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting

  • Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!

    Don't miss out on this chance to elevate your knowledge and skills in pharmacology! Allow registrants to appreciate the incredible versatility of GPCRs and how small molecules can affect

  • 📰 GPCR Weekly News, February 5 to 11, 2024

    You can sign up for our waitlist. We will be offering this live course later this year. If you are on the waitlist, you'll be the first notified and can register for the course ahead of everyone cAMP signaling in the Hedgehog pathway Unraveling the Interplay of Extracellular Domain Conformational Changes

  • 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)

    Allostery of G-Protein-Coupled Receptors Industry News Sosei Heptares to take back GPCR agonist after GSK changes

  • 📰 GPCR Weekly News, April 24 to 30, 2023

    GPCRs in Neuroscience Evidence that RXFP4 is located in enterochromaffin cells and can regulate production WNT stimulation induces dynamic conformational changes in the Frizzled-Dishevelled interaction.

  • 📰 GPCR Weekly News, November 13 to 19, 2023

    cannabidiol, on the cannabinoid CB2 receptor GPCRs in Cardiology, Endocrinology, and Taste Transcriptomic changes

  • 📰 GPCR Weekly News, March 13 to 19, 2023

    Remember, you can always adjust your email preferences in your account settings. For Dr. There is no limit to the number of posters we can accommodate, so hurry and submit your poster so that we can add it to the list of posters and increase the number of people who can ''stop by'' it tomorrow GPCRs in Neuroscience Physiological Condition-Dependent Changes in Ciliary GPCR Localization in the Brain

  • 📰 GPCR Weekly News, April 22 to 28, 2024

    Also, Mark Schmeizl can help you find your perfect match if you want to hire or be hired. microbial metabolites and GPCRome in Alzheimer's disease Methods & Updates in GPCR Research Single-chain

  • 📰 GPCR Weekly News

    Quantification of changes in human islet G protein-coupled receptor mRNA expression in obesity.

  • 📰 GPCR Weekly News, June 17 to 23, 2024

    mechanotransduction at endothelial junctions GPCRs in Neuroscience Male-specific behavioral and transcriptomic changes Epilepsy Models Biophysicists decipher functionality of adrenaline-binding receptor Tectonic plates more than

  • Regulators of G-protein signaling: essential players in GPCR signaling

    Upon activation, GPCRs have conformational changes that allow the coupling and subsequent activation Liu-Chen, and J.R.

  • New role of β-arrestins in MOR signaling

    under Gi/o activation-MOR, being crucial the formation of β-arrestin/ β2-adaptin and clathrin heavy chain If you are interested in learning more about the molecular details of this study, you can consult the

  • 📰 GPCR Weekly News, February 19 to 25, 2024

    You can still sign up for our waitlist. We will be offering this live course again later this year. Whole Brain Mapping of Orexin Receptor mRNA Expression Visualized by Branched In Situ Hybridization Chain

  • Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation

    trigger receptor internalization via interaction with the adaptor protein 2 (AP2) and clathrin heavy chain Lipid molecules, such as phosphoinositides, can bind to specific domains of β-arrestins, promoting their Therefore the lipid composition of the bilayer can influence the kinetics and efficiency of β-arrestin

  • Targeting Intracellular Allosteric Sites in GPCRs

    These sites act as molecular switches that can modulate receptor activity, providing an untapped opportunity Alternatively, they can function as neutral allosteric ligands (NALs), binding to a receptor's allosteric : 1) affinity modulation where the resulting change in conformation can influence the orthosteric binding Moreover, they have the potential to enhance target selectivity, which can arise from greater sequence Allosteric agonists binding to intracellular sites can also promote G-protein signaling.

  • 📰 GPCR Weekly News, March 25 to March 31, 2024

    GPCR Ecosystem group, where you can find Dr. GPCR Symposia With a premium membership, you can watch on-demand the Dr. If you want to showcase your research, you can submit a poster presentation to our community, take advantage Sosei Heptares Confirms Re-election of its Board and Executive Management Team and the Approval of Change

  • GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024

    Premium members can enjoy a 25% OFF early bird discount , but hurry - it's only available for a limited Don’t miss this chance to benefit from our early bird pricing and premium content. Degradation Modalities A quick revision of how β-adrenergic receptors work and how their antagonists can

  • Overview of adhesion GPCRs self-activation

    Through cell-based assays and Cryo-EM of high quality, it was possible to know that ADGRL3 can activate each G protein with the receptor showed that there are more polar interactions in Gq/Gs engagements than structural perspective, the -4 position of αH5 was key for the selectivity of G-protein coupling, since the change ., Zhu, X., Wang, N., Xu, Z., Xia, R., Liang, J., Duan, Y., Yin, H., Xiong, Y., Zhang, A., Guo, C., Chen

  • Feeder or trigger – CCR2 as a scavenger and regulator of cell migration

    with CCR2, indicating that β-arrestin regulates scavenging and signaling of CCR1 to a greater extent than 2000), becoming incapable of promoting cell migration, a phenomenon which is likely to be mediated by changes

  • An overview of the compartmentalized GPCR Signaling: Relevance and Implications

    the lipid composition of intracellular membranes may influence GPCR dynamics and signaling outcomes, changing Showing that this spatially biased signaling through arrestins can influence transcriptional responses addition to endosomal signaling, GPCRs are also known to localize to the Golgi apparatus, where they can Additionally, the conditions within endosomes, such as low pH and high protease activity, can degrade Pharmaceuticals (Basel, Switzerland), 14(5), 439. https://doi.org/10.3390/ph14050439 Chen, K.

  • Artificial intelligence – faster, smarter, cheaper GPCR drug discovery

    assays, signaling assays, cell imaging, protein structure determination, and omics applications, which can Classification: AI models can be used to distinguish GPCRs from non-GPCRs, and to classify GPCRs into Mutations: ML methods can determine stabilising mutations that enable structure determination and can Virtual screening: molecular docking and virtual screening can efficiently analyze large databases of sites (orthosteric, allosteric), activation mechanisms, and conformational changes. 8.

  • Unlocking the Therapeutic Potential of Previously Undruggable GPCRs

    These receptors have much larger binding pockets than the majority of GPCRs that have been successfully of ligand-receptor interface for these GPCRs makes modulation with small molecule drugs, when they can ’ interaction ensures that all molecules in the library are specific for the target receptor rather than The PROcisionXᵀᴹ platform (summarized in Figure 2) can be used to complete a discovery campaign within Orion’s CCR2 antagonist analog (OB-004), discovered in only 6 months, is considerably more potent than

bottom of page